A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality

A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality

<i>Introduction</i>: This study aimed to evaluate the long-term adverse effects on the physical appearance and overall well-being of breast cancer patients who receive hypofractionated radiotherapy as whole breast and simultaneous integrated boost (SIB) treatment, utilizing intensive mod...

Full description

Bibliographic Details
Main Authors: Zuleyha Akgun, Aydin Cakir, Esra Sağlam, Sertac Demirel, Abdullah Igci, Serkan Keskin
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medicina
Subjects:
breast cancer
SIB
hypofractionation
hybrid radiotherapy
late toxicity
Online Access:https://www.mdpi.com/1648-9144/59/4/675

Internet

https://www.mdpi.com/1648-9144/59/4/675

Similar Items